SEC Form 4 · accession 0001140361-16-073916
Vaxart, Inc. · VXRT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark P Colonnese
Officer — CFO and EVP
Period of report
Jul 27, 2016
Accepted (ET)
Jul 29, 2016 · 4:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000072444
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $1.34 | Jul 27, 2016 | A | 150,000 | A | Jul 27, 2017 | Jul 27, 2026 | Common Stock | 150,000 | 375,000 | D |
Explanation of responses
- F1The stock option vests in equal annual installments beginning on the first anniversary and thereafter on the second and third anniversary ratably.